SPOTLIGHT -
Fort Lauderdale, FL-An increase in outflow facility appears to be the mechanism by which unoprostone isopropyl ophthalmic solution (Rescula 0.15%, Novartis) reduces IOP, said Carol B. Toris, PhD.
Verana Health launches its Qdata Thyroid Eye Disease module
(EyePod) From idea to impact: Navigating ophthalmic innovation
Phoenix-Micron Inc and ArtiKode Intelligence team up to enhance OCT imaging with AI
EyePod: Modifier Gene Therapy: What is it?
Orbis, FundamentalVR team up to target training
Ocugen completes dosing of subjects with geographic atrophy in Cohort 2 of Phase 1/2 ArMaDa clinical trial of OCU410